Vivani Medical, INC Form 4 insider transactions

Vivani Medical, Inc. Director Alexandra L. Popoff was granted 35,135 non-qualified stock options with an exercise price of $1.27 per share as part of her annual compensation.

Vivani Medical, Inc.'s Chief Financial Officer, Anthony Baldor, was granted 600,000 stock options with a 10-year term and a vesting schedule tied to continued service.

Gregg Williams, a director and 10% owner of Vivani Medical, has increased his beneficial ownership through a series of open market purchases of common stock.

Donald Dwyer, Chief Business Officer of Vivani Medical, reports acquisition of stock options and restricted stock units (RSUs) in the company.

Brigid Makes, CFO of Vivani Medical, reports the acquisition of stock options and restricted stock units (RSUs) in the company.

Chief Operations Officer Le Truc of Vivani Medical, Inc. reports the acquisition of stock options and restricted stock units (RSUs) on May 12, 2025.

Lisa Porter, Chief Medical Officer of Vivani Medical, reports the acquisition of stock options and restricted stock units (RSUs) in a recent SEC filing.

Adam Mendelsohn, CEO of Vivani Medical, acquired stock options and restricted stock units (RSUs) on May 12, 2025, according to a Form 4 filing.

Director Gregg Williams increases his stake in Vivani Medical through open market purchases and indirect holdings.

Director Gregg Williams increased his holdings in Vivani Medical through open market purchases.

Director Gregg Williams reports purchasing additional shares of Vivani Medical, Inc. on the open market, increasing his indirect holdings.

Director Gregg Williams reports multiple open market purchases of Vivani Medical (VANI) common stock, both directly and indirectly through various trusts and LLCs.

Director Gregg Williams reports purchasing additional shares of Vivani Medical, Inc. on April 2nd and 3rd, 2025.

Chief Business Officer Donald Dwyer of Vivani Medical, Inc. (VANI) purchased 4,000 shares of common stock on the open market at a price of $1.025 per share on April 1, 2025.

Donald Dwyer, Chief Business Officer of Vivani Medical, Inc., purchased 1,000 shares of common stock on the open market at a price of $1.11 per share on February 28, 2025.

Vivani Medical director Daniel Bradbury acquired 50,059 stock options in lieu of a $45,000 cash retainer, according to a recent SEC filing.

Director Gregg Williams acquired 76,757 stock options in Vivani Medical, Inc. in lieu of a $69,000 cash retainer.

Gregg Williams, a director at Vivani Medical, purchased 3,968,253 shares of common stock in a private sale for $5 million, increasing his total holdings to over 18 million shares.

Donald Dwyer, Chief Business Officer of Vivani Medical, Inc., reports purchasing additional shares of the company's common stock in the open market over three days in October 2024.

Chief Business Officer Donald Dwyer recently purchased additional shares of Vivani Medical, Inc. on the open market.

Donald Dwyer, Chief Business Officer of Vivani Medical, Inc., reports purchasing 2,000 shares of common stock at $0.96 per share on November 22, 2023.

Gregg Williams, a director at Vivani Medical, was granted stock options for 34,839 shares of common stock on June 27, 2024.

Dean Baker, a director at Vivani Medical, received stock options and granted a limited power of attorney for SEC filings.

Director Daniel Bradbury received an annual grant of 34,839 stock options in Vivani Medical, Inc.

Alexandra Larson, a director at Vivani Medical, reported the acquisition of stock options on June 27, 2024, according to a Form 4 filing.

Aaron Mendelsohn, a director at Vivani Medical, Inc., was granted stock options on June 27, 2024, according to a recent SEC filing.

Truc Le, Chief Operations Officer of Vivani Medical, receives stock options and restricted stock units, as detailed in a recent SEC filing.

Lisa Porter, Chief Medical Officer of Vivani Medical, received stock options for 80,000 shares and 40,000 restricted stock units (RSUs) on May 10, 2024, as disclosed in a recent SEC filing.

Adam Mendelsohn, CEO of Vivani Medical, reports the acquisition of stock options and restricted stock units (RSUs) in a recent SEC filing.

Donald Dwyer, Chief Business Officer of Vivani Medical, received stock options and restricted stock units (RSUs) as part of his compensation.